Eli Lilly and CompanyvsZymeworks

LLY and ZYME stock compared: price, dividend, valuation and results, from SEC filings.

LLY

Eli Lilly and Company

$1,427.77

Value $1.35T

-0.32%
LLY's page

Eli Lilly and Company (LLY) has a market value of $1.35T and Zymeworks (ZYME) $1.8B. Over the last year, with dividends, LLY moved +40.0% and ZYME +41.8%. The P/E is 48.8 for LLY and 41.9 for ZYME. Dividend yield: LLY 0.44%, ZYME none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LLY$1.35T

    ZYME$1.8B

    LLY is 743 times ZYME

  • Revenue, 12 months

    LLY$86.5B

    ZYME$266M

    LLY is 325 times ZYME

  • Net income, 12 months

    LLY$27.6B

    ZYME$43M

    LLY is 637 times ZYME

  • Operating margin

    LLY–

    ZYME16.6%

  • ROIC

    LLY35.5%

    ZYME16.0%

    19.5 points apart

  • P/E

    LLY48.8

    ZYME41.9

    LLY is 1.2 times ZYME

  • Dividend yield

    LLY0.4%

    ZYME0.0%

    0.4 points apart

  • 5-year return

    LLY+478.1%

    ZYME+32.0%

    446.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LLY+478.1%

ZYME+32.0%

020040060020222023202420252026
Returns by period
PeriodLLYWith dividendsZYMEWith dividends
1 year since November 14, 2025+40.0%Price +39.2%+41.8%Price +41.8%
3 years since November 17, 2023+146.0%+35.0% a yearPrice +141.2%+220.6%+47.5% a yearPrice +220.6%
5 years since November 16, 2021+478.1%+42.0% a yearPrice +453.7%+32.0%+5.7% a yearPrice +32.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LLYEli Lilly and CompanyZYMEZymeworks

Valuation

LLYZYME
Valuation
Price$1,427.77$26.26
Market value$1.35T$1.8B
Enterprise value (EV)$1.39T$2.1B
P/E48.841.9
P/E, 5-year median49.9–
P/B33.57.0
EV/EBIT40.046.5
Free cash flow yield1.5%–

Results and growth

LLYZYME
Results and growth
Revenue, 12 months$86.5B$266M
Net income, 12 months$27.6B$43M
Free cash flow, 12 months$19.7B-$113M
Earnings per share, 12 months$30.81$0.63
Revenue growth, year on year44.7%38.9%
Revenue growth a year, past+21.6%over 5 years+22.2%over 5 years
EPS growth a year, past+27.6%over 5 years–

Margins and returns on capital

LLYZYME
Margins and returns on capital
Gross margin83.6%–
Operating margin–16.6%
Net margin31.9%16.3%
ROIC35.5%16.0%
ROE88.6%19.9%

Balance sheet

LLYZYME
Balance sheet
Cash$4.9B$100M
Total debt$49.5B$392M
Net debt / EBITDA1.25.0
Interest cover38.9×–

Dividends and buybacks

LLYZYME
Dividends and buybacks
Dividend yield0.4%–
Dividend per share, 12 months$6.34–
Dividend growth a year, past+15.2%over 5 years–
Buyback yield0.3%2.3%
Shareholder yield0.7%2.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LLY or ZYME

Didn't find what you were looking for?

Ask us
Which is bigger, Eli Lilly and Company or Zymeworks?

By market value, Eli Lilly and Company ($1.35T) is about 743.1 times Zymeworks ($1.8B), at today's prices.

How did LLY and ZYME stock do over the last 5 years?

Since November 16, 2021, LLY's price moved +453.7% and ZYME's +32.0%. With dividends: LLY +478.1% (+42.0% a year), ZYME +32.0% (+5.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, LLY or ZYME?

The dividend yield at today's price is 0.44% for Eli Lilly and Company and none for Zymeworks. Over the last twelve months they paid $6.34 and – per share.

What is the P/E of LLY and ZYME?

At today's price, the P/E is 48.8 for LLY and 41.9 for ZYME. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Eli Lilly and Company or Zymeworks?

Over the last twelve months, the net margin was 31.9% for Eli Lilly and Company and 16.3% for Zymeworks, and the operating margin – and 16.6%. Revenue was $86.5B and $266M.

Which is the better investment, Eli Lilly and Company or Zymeworks?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.